Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Sodium Bicarbonate in Cystic Fibrosis
NCT03391414Phase 1Completed
- Start
- Aug 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of sodium bicarbonate in cystic fibrosis (CF). Primary endpoint: Exhaled breath condensate pH change at 4 hours. Started Aug 2014; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03391414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03391414.